Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Page 1
Coagulation-monitored, dose-adjusted catheter-directed thrombolysis or pharmaco-mechanical thrombus removal in deep vein thrombosis.
Wortmann JK, Barco S, Fumagalli RM, Voci D, Hügel U, Cola R, Spirk D, Kucher N, Sebastian T. Wortmann JK, et al. Among authors: kucher n. Vasa. 2023 Nov;52(6):416-422. doi: 10.1024/0301-1526/a001097. Epub 2023 Oct 17. Vasa. 2023. PMID: 37847240 Free article.
Conclusions: The use of PMT and CDT for iliofemoral DVT was overall safe and resulted in high long-term patency and treatment success. Given the less severe presentation of DVT, single-session PMT appeared to be characterized by numerically better primary patency and lower …
Conclusions: The use of PMT and CDT for iliofemoral DVT was overall safe and resulted in high long-term patency and treatment success …
Acute on Chronic Thromboembolic Pulmonary Hypertension: Case Series and Review of Management.
Opitz I, Patella M, Lauk O, Inci I, Bettex D, Horisberger T, Schüpbach R, Keller DI, Frauenfelder T, Kucher N, Granton J, Pfammatter T, de Perrot M, Ulrich S. Opitz I, et al. Among authors: kucher n. J Clin Med. 2022 Jul 21;11(14):4224. doi: 10.3390/jcm11144224. J Clin Med. 2022. PMID: 35887991 Free PMC article. Review.
Identifying an underlying and undiagnosed CTEPH during acute PE, while challenging, is an important consideration as it will alter the patients' acute and long-term management. Differential diagnosis and evaluation require an interdisciplinary expert team. ...
Identifying an underlying and undiagnosed CTEPH during acute PE, while challenging, is an important consideration as it will alter the patie …
Impact of concomitant popliteal vein thrombosis in patients with acute iliofemoral deep vein thrombosis treated with endovascular early thrombus removal.
Frey V, Sebastian T, Barco S, Spirk D, Hayoz D, Périard D, Kucher N, Betticher D, Engelberger RP. Frey V, et al. Among authors: kucher n. Vasa. 2022 Sep;51(5):282-290. doi: 10.1024/0301-1526/a001017. Epub 2022 Jul 1. Vasa. 2022. PMID: 35774017 Free article. Clinical Trial.
However, post-thrombotic popliteal vein lesions and reflux are more frequent in IF-DVT patients with popliteal involvement. Their impact on long-term outcomes remains to be investigated....
However, post-thrombotic popliteal vein lesions and reflux are more frequent in IF-DVT patients with popliteal involvement. Their impact on …
Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: a structured protocol summary of the "SirPAD" randomized controlled trial.
Barco S, Sebastian T, Voci D, Engelberger RP, Grigorean A, Holy E, Leeger C, Münger M, Périard D, Probst E, Spescha R, Held U, Kucher N. Barco S, et al. Among authors: kucher n. Trials. 2022 Apr 21;23(1):334. doi: 10.1186/s13063-022-06242-8. Trials. 2022. PMID: 35449070 Free PMC article.
Finally, it remains unclear whether paclitaxel-coated balloons may impair long-term survival. Alternative drug-coated balloons, the so-called limus-based analogs, have been approved for clinical use in patients with peripheral arterial disease. ...
Finally, it remains unclear whether paclitaxel-coated balloons may impair long-term survival. Alternative drug-coated balloons, the s …
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis.
Pleming W, Barco S, Voci D, Sacco C, Zane F, Granziera S, Corsi G, Konstantinides SV, Kucher N, Pecci A, Valerio L. Pleming W, et al. Among authors: kucher n. Hamostaseologie. 2022 Aug;42(4):261-267. doi: 10.1055/a-1694-8723. Epub 2022 Mar 7. Hamostaseologie. 2022. PMID: 35255510 Free PMC article.
CONCLUSIONS: While Lemierre syndrome is known to be primarily characterized by venous thromboembolic events, our results suggest that local or distant arterial complications may occur in approximately one-tenth of patients and may be associated with a greater risk of long-term …
CONCLUSIONS: While Lemierre syndrome is known to be primarily characterized by venous thromboembolic events, our results suggest that local …
Transient perivascular inflammation of the carotid artery (TIPIC) syndrome.
Micieli E, Voci D, Mumoli N, Mastroiacovo D, Grigorean A, Obadia M, de Champfleur NM, Naggara O, Carsin B, Amor-Sahli M, Cottier JP, Bensoussan J, Auffray-Calvier E, Varoquaux A, Bonneville F, Sadik JC, Kucher N, Lecler A, Barco S. Micieli E, et al. Among authors: kucher n. Vasa. 2022 Mar;51(2):71-77. doi: 10.1024/0301-1526/a000989. Epub 2022 Feb 8. Vasa. 2022. PMID: 35130715 Free article.
Conclusions: The present analysis elucidates clinical and sonographic characteristics of TIPIC syndrome, indicating the benign nature of this condition. A future international registry will study the long-term course of the disease....
Conclusions: The present analysis elucidates clinical and sonographic characteristics of TIPIC syndrome, indicating the benign nature of thi …
Reperfusion Treatment for Acute Pulmonary Embolism.
Engelberger RP, Kucher N. Engelberger RP, et al. Among authors: kucher n. Hamostaseologie. 2018 May;38(2):98-105. doi: 10.1055/s-0038-1641717. Epub 2018 May 29. Hamostaseologie. 2018. PMID: 29843174 Review.
While the early benefits of reperfusion therapy are well documented, evidence for long-term benefit is still scarce. The scope of this review is to summarize the evidence for the currently available reperfusion therapies in the management of acute pulmonary embolism....
While the early benefits of reperfusion therapy are well documented, evidence for long-term benefit is still scarce. The scope of thi …
Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.
Lauber S, Limacher A, Tritschler T, Stalder O, Méan M, Righini M, Aschwanden M, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J, Angelillo-Scherrer A, Matter CM, Husmann M, Banyai M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky D. Lauber S, et al. Among authors: kucher n. Am J Med. 2018 Jun;131(6):703.e7-703.e16. doi: 10.1016/j.amjmed.2017.12.015. Epub 2018 Jan 4. Am J Med. 2018. PMID: 29307536
CONCLUSIONS: Elderly patients with acute venous thromboembolism have a substantial long-term risk of recurrent venous thromboembolism, and recurrence carries a high case-fatality rate. ...
CONCLUSIONS: Elderly patients with acute venous thromboembolism have a substantial long-term risk of recurrent venous thromboembolism …
Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
Nagler M, Angelillo-Scherrer A, Méan M, Limacher A, Abbal C, Righini M, Beer JH, Osterwalder J, Frauchiger B, Aschwanden M, Matter CM, Kucher N, Cornuz J, Banyai M, Husmann M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky D. Nagler M, et al. Among authors: kucher n. J Thromb Haemost. 2017 Nov;15(11):2165-2175. doi: 10.1111/jth.13810. Epub 2017 Sep 25. J Thromb Haemost. 2017. PMID: 28834238 Free article.
Essentials The long-term effects of VKORC1 and CYP2C9 variants on clinical outcomes remains unclear. ...Objectives We examined the association between CYP2C9/VKORC1 variants and long-term clinical outcomes in a prospective cohort study of elderly patients treated wi …
Essentials The long-term effects of VKORC1 and CYP2C9 variants on clinical outcomes remains unclear. ...Objectives We examined the as …
21 results